Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Graig Suvannavejh is an analyst at Mizuho. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/09/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 07/08/2024 | IDYA | Buy Now | IDEAYA Biosciences | $40.20 | 24.38% | → $50 | Initiates | → Outperform | Get Alert |
| 07/08/2024 | NMRA | Buy Now | Neumora Therapeutics | $10.38 | 92.68% | → $20 | Initiates | → Outperform | Get Alert |
| 06/21/2024 | ITCI | Buy Now | Intra-Cellular Therapies | $72.73 | 37.49% | $96 → $100 | Maintains | Buy | Get Alert |
| 06/12/2024 | AXSM | Buy Now | Axsome Therapeutics | $81.30 | 30.38% | — | Reiterates | Buy → Buy | Get Alert |
| 06/07/2024 | INSM | Buy Now | Insmed | $69.97 | 17.2% | $36 → $82 | Maintains | Buy | Get Alert |
| 05/17/2024 | ADAP | Buy Now | Adaptimmune Therapeutics | $1.18 | 154.24% | $9 → $3 | Maintains | Buy | Get Alert |
| 05/16/2024 | IMTX | Buy Now | Immatics | $12.07 | 32.56% | $14 → $16 | Maintains | Buy | Get Alert |
| 05/14/2024 | AMLX | Buy Now | Amylyx Pharma | $1.66 | 80.72% | $4 → $3 | Maintains | Neutral | Get Alert |
| 05/13/2024 | INSM | Buy Now | Insmed | $69.97 | -48.55% | $35 → $36 | Maintains | Buy | Get Alert |
| 05/13/2024 | IMCR | Buy Now | Immunocore Hldgs | $37.46 | 134.92% | $90 → $88 | Maintains | Buy | Get Alert |
| 05/08/2024 | AXSM | Buy Now | Axsome Therapeutics | $81.30 | 30.38% | $109 → $106 | Maintains | Buy | Get Alert |
| 05/07/2024 | EYPT | Buy Now | EyePoint Pharmaceuticals | $8.65 | 246.82% | $39 → $30 | Maintains | Buy | Get Alert |
| 04/29/2024 | APLS | Buy Now | Apellis Pharmaceuticals | $37.01 | 40.5% | $60 → $52 | Maintains | Neutral | Get Alert |
| 04/29/2024 | ADVM | Buy Now | Adverum Biotechnologies | $7.18 | 206.41% | $40 → $22 | Maintains | Buy | Get Alert |
| 04/22/2024 | ITCI | Buy Now | Intra-Cellular Therapies | $72.73 | 32% | $82 → $96 | Maintains | Buy | Get Alert |
| 04/02/2024 | IMRX | Buy Now | Immuneering | $1.12 | 614.29% | $20 → $8 | Maintains | Buy | Get Alert |
| 03/28/2024 | AXSM | Buy Now | Axsome Therapeutics | $81.30 | 34.07% | $108 → $109 | Maintains | Buy | Get Alert |
| 03/27/2024 | CRVS | Buy Now | Corvus Pharma | $1.86 | 88.17% | $3.5 → $3.5 | Maintains | Neutral | Get Alert |
| 03/27/2024 | APLS | Buy Now | Apellis Pharmaceuticals | $37.01 | 62.12% | $60 → $60 | Maintains | Neutral | Get Alert |
| 03/08/2024 | AMLX | Buy Now | Amylyx Pharma | $1.66 | 1827.71% | $27 → $32 | Reiterates | Buy → Buy | Get Alert |
| 03/05/2024 | IMCR | Buy Now | Immunocore Hldgs | $37.46 | 140.26% | $86 → $90 | Maintains | Buy | Get Alert |
| 02/27/2024 | HRMY | Buy Now | Harmony Biosciences | $34.35 | 16.45% | $42 → $40 | Maintains | Buy | Get Alert |
| 02/27/2024 | AXSM | Buy Now | Axsome Therapeutics | $81.30 | 32.84% | $112 → $108 | Maintains | Buy | Get Alert |
| 02/16/2024 | ITCI | Buy Now | Intra-Cellular Therapies | $72.73 | 12.75% | $76 → $82 | Maintains | Buy | Get Alert |
| 02/16/2024 | IMCR | Buy Now | Immunocore Hldgs | $37.46 | 129.58% | $72 → $86 | Maintains | Buy | Get Alert |
| 02/16/2024 | HRMY | Buy Now | Harmony Biosciences | $34.35 | 22.27% | $33 → $42 | Maintains | Buy | Get Alert |
| 02/16/2024 | EYPT | Buy Now | EyePoint Pharmaceuticals | $8.65 | 350.87% | $30 → $39 | Maintains | Buy | Get Alert |
| 02/16/2024 | CERE | Buy Now | Cerevel Therapeutics Hldg | $40.59 | 10.86% | $25 → $45 | Maintains | Neutral | Get Alert |
| 02/16/2024 | AXSM | Buy Now | Axsome Therapeutics | $81.30 | 37.76% | $90 → $112 | Maintains | Buy | Get Alert |
| 02/16/2024 | APLS | Buy Now | Apellis Pharmaceuticals | $37.01 | 62.12% | $49 → $60 | Maintains | Neutral | Get Alert |
| 02/06/2024 | ADVM | Buy Now | Adverum Biotechnologies | $7.18 | -44.29% | $20 → $40 | Maintains | Buy | Get Alert |
| 01/18/2024 | HALO | Buy Now | Halozyme Therapeutics | $52.75 | -24.17% | $45 → $40 | Maintains | Neutral | Get Alert |
| 12/21/2023 | AMLX | Buy Now | Amylyx Pharma | $1.66 | 1526.51% | $46 → $27 | Maintains | Buy | Get Alert |
| 12/07/2023 | EYPT | Buy Now | EyePoint Pharmaceuticals | $8.65 | 246.82% | $20 → $30 | Maintains | Buy | Get Alert |
| 11/27/2023 | TERN | Buy Now | Terns Pharma | $7.45 | 34.23% | $17 → $10 | Maintains | Buy | Get Alert |
| 11/17/2023 | ALEC | Buy Now | Alector | $4.89 | 84.05% | $10 → $9 | Maintains | Buy | Get Alert |
| 11/02/2023 | EYPT | Buy Now | EyePoint Pharmaceuticals | $8.65 | 131.21% | → $20 | Initiates | → Buy | Get Alert |
| 11/02/2023 | ADVM | Buy Now | Adverum Biotechnologies | $7.18 | -72.14% | → $20 | Initiates | → Buy | Get Alert |
| 11/02/2023 | APLS | Buy Now | Apellis Pharmaceuticals | $37.01 | 13.48% | → $42 | Initiates | → Neutral | Get Alert |
| 10/04/2023 | HRMY | Buy Now | Harmony Biosciences | $34.35 | 57.21% | → $54 | Reiterates | Buy → Buy | Get Alert |
| 09/25/2023 | AXSM | Buy Now | Axsome Therapeutics | $81.30 | 23% | → $100 | Reiterates | Buy → Buy | Get Alert |
| 09/19/2023 | HRMY | Buy Now | Harmony Biosciences | $34.35 | 57.21% | $54 → $54 | Maintains | Buy | Get Alert |
| 08/29/2023 | HRMY | Buy Now | Harmony Biosciences | $34.35 | 57.21% | → $54 | Reiterates | Buy → Buy | Get Alert |
| 08/28/2023 | AXSM | Buy Now | Axsome Therapeutics | $81.30 | 23% | → $100 | Reiterates | Buy → Buy | Get Alert |
| 08/23/2023 | BTAI | Buy Now | BioXcel Therapeutics | $1.13 | 253.98% | → $4 | Reiterates | Neutral → Neutral | Get Alert |
| 08/15/2023 | BTAI | Buy Now | BioXcel Therapeutics | $1.13 | 253.98% | $40 → $4 | Downgrade | Buy → Neutral | Get Alert |
| 08/11/2023 | AXSM | Buy Now | Axsome Therapeutics | $81.30 | 23% | $95 → $100 | Maintains | Buy | Get Alert |
| 08/11/2023 | ALEC | Buy Now | Alector | $4.89 | 104.5% | $12 → $10 | Maintains | Buy | Get Alert |
| 08/07/2023 | CERE | Buy Now | Cerevel Therapeutics Hldg | $40.59 | -38.41% | $29 → $25 | Maintains | Neutral | Get Alert |
| 08/04/2023 | KRTX | Buy Now | Karuna Therapeutics | — | — | $274 → $258 | Maintains | Buy | Get Alert |
| 08/03/2023 | HRMY | Buy Now | Harmony Biosciences | $34.35 | 57.21% | $60 → $54 | Maintains | Buy | Get Alert |
| 07/24/2023 | HALO | Buy Now | Halozyme Therapeutics | $52.75 | -14.69% | $43 → $45 | Downgrade | Buy → Neutral | Get Alert |
| 06/30/2023 | BTAI | Buy Now | BioXcel Therapeutics | $1.13 | 3439.82% | → $40 | Reiterates | Buy → Buy | Get Alert |
| 06/30/2023 | TERN | Buy Now | Terns Pharma | $7.45 | 114.77% | → $16 | Reiterates | Buy → Buy | Get Alert |
| 06/27/2023 | TERN | Buy Now | Terns Pharma | $7.45 | 114.77% | → $16 | Reiterates | Buy → Buy | Get Alert |
| 06/22/2023 | TERN | Buy Now | Terns Pharma | $7.45 | 114.77% | → $16 | Initiates | → Buy | Get Alert |
| 06/14/2023 | AXSM | Buy Now | Axsome Therapeutics | $81.30 | 16.85% | → $95 | Reiterates | Buy → Buy | Get Alert |
| 06/12/2023 | AXSM | Buy Now | Axsome Therapeutics | $81.30 | 16.85% | → $95 | Reiterates | Buy → Buy | Get Alert |
| 06/05/2023 | RAIN | Buy Now | Rain Oncology | — | — | $17 → $1 | Downgrade | Buy → Neutral | Get Alert |
| 05/15/2023 | AMLX | Buy Now | Amylyx Pharma | $1.66 | 2912.05% | $52 → $50 | Maintains | Buy | Get Alert |
| 05/15/2023 | ATHA | Buy Now | Athira Pharma | $2.65 | 88.68% | $6 → $5 | Maintains | Buy | Get Alert |
| 05/11/2023 | IMCR | Buy Now | Immunocore Hldgs | $37.46 | 97.54% | $70 → $74 | Maintains | Buy | Get Alert |
| 05/11/2023 | AXSM | Buy Now | Axsome Therapeutics | $81.30 | 16.85% | $84 → $95 | Maintains | Buy | Get Alert |
| 05/10/2023 | BTAI | Buy Now | BioXcel Therapeutics | $1.13 | 3439.82% | $38 → $40 | Maintains | Buy | Get Alert |
| 05/08/2023 | CERE | Buy Now | Cerevel Therapeutics Hldg | $40.59 | -28.55% | $26 → $29 | Maintains | Neutral | Get Alert |
| 05/08/2023 | KRTX | Buy Now | Karuna Therapeutics | — | — | $270 → $274 | Maintains | Buy | Get Alert |
| 05/08/2023 | ITCI | Buy Now | Intra-Cellular Therapies | $72.73 | 4.5% | $74 → $76 | Maintains | Buy | Get Alert |
| 03/31/2023 | IMCR | Buy Now | Immunocore Hldgs | $37.46 | 86.87% | → $70 | Initiates | → Buy | Get Alert |
| 03/31/2023 | IMTX | Buy Now | Immatics | $12.07 | -0.58% | → $12 | Initiates | → Buy | Get Alert |
| 03/31/2023 | VIGL | Buy Now | Vigil Neuroscience | $4.02 | 273.13% | → $15 | Initiates | → Buy | Get Alert |
| 03/31/2023 | AMLX | Buy Now | Amylyx Pharma | $1.66 | 3032.53% | → $52 | Initiates | → Buy | Get Alert |
| 03/30/2023 | HRMY | Buy Now | Harmony Biosciences | $34.35 | 74.67% | → $60 | Reiterates | → Buy | Get Alert |
| 03/30/2023 | ITCI | Buy Now | Intra-Cellular Therapies | $72.73 | 1.75% | $66 → $74 | Maintains | Buy | Get Alert |
| 03/29/2023 | ITCI | Buy Now | Intra-Cellular Therapies | $72.73 | 1.75% | $66 → $74 | Maintains | Buy | Get Alert |
| 03/29/2023 | HRMY | Buy Now | Harmony Biosciences | $34.35 | 74.67% | → $60 | Reiterates | → Buy | Get Alert |
| 03/13/2023 | AXSM | Buy Now | Axsome Therapeutics | $81.30 | 3.32% | → $84 | Reiterates | → Buy | Get Alert |
| 03/13/2023 | RAIN | Buy Now | Rain Oncology | — | — | $18 → $17 | Maintains | Buy | Get Alert |
| 03/09/2023 | CERE | Buy Now | Cerevel Therapeutics Hldg | $40.59 | -35.94% | $28 → $26 | Maintains | Neutral | Get Alert |
| 03/01/2023 | AXSM | Buy Now | Axsome Therapeutics | $81.30 | 3.32% | $86 → $84 | Maintains | Buy | Get Alert |
| 02/22/2023 | HRMY | Buy Now | Harmony Biosciences | $34.35 | 74.67% | $70 → $60 | Maintains | Buy | Get Alert |
| 02/10/2023 | RAIN | Buy Now | Rain Oncology | — | — | → $18 | Reiterates | → Buy | Get Alert |
| 02/08/2023 | BTAI | Buy Now | BioXcel Therapeutics | $1.13 | 3262.83% | $24 → $38 | Maintains | Buy | Get Alert |
| 01/30/2023 | AXSM | Buy Now | Axsome Therapeutics | $81.30 | 5.78% | $80 → $86 | Maintains | Buy | Get Alert |
| 01/23/2023 | RAIN | Buy Now | Rain Oncology | — | — | → $18 | Initiates | → Buy | Get Alert |
| 12/09/2022 | KRTX | Buy Now | Karuna Therapeutics | — | — | $276 → $270 | Assumes | → Buy | Get Alert |
| 12/09/2022 | INSM | Buy Now | Insmed | $69.97 | -59.98% | → $28 | Initiates | → Buy | Get Alert |
| 11/16/2022 | BTAI | Buy Now | BioXcel Therapeutics | $1.13 | 1492.92% | $19 → $18 | Maintains | Buy | Get Alert |
| 11/11/2022 | BTAI | Buy Now | BioXcel Therapeutics | $1.13 | 1492.92% | $19 → $18 | Maintains | Buy | Get Alert |
| 11/10/2022 | RYTM | Buy Now | Rhythm Pharmaceuticals | $43.67 | -19.85% | $31 → $35 | Maintains | Buy | Get Alert |
| 11/10/2022 | KOD | Buy Now | Kodiak Sciences | $2.44 | 227.87% | $9 → $8 | Maintains | Neutral | Get Alert |
| 11/10/2022 | CERE | Buy Now | Cerevel Therapeutics Hldg | $40.59 | -31.02% | $32 → $28 | Maintains | Neutral | Get Alert |
| 11/09/2022 | AXSM | Buy Now | Axsome Therapeutics | $81.30 | -1.6% | $76 → $80 | Maintains | Buy | Get Alert |
| 11/08/2022 | HRMY | Buy Now | Harmony Biosciences | $34.35 | 103.78% | $60 → $70 | Maintains | Buy | Get Alert |
| 09/07/2022 | AXSM | Buy Now | Axsome Therapeutics | $81.30 | -6.52% | → $76 | Assumes | → Buy | Get Alert |
| 08/23/2022 | CERE | Buy Now | Cerevel Therapeutics Hldg | $40.59 | -21.16% | $27 → $32 | Maintains | Neutral | Get Alert |
| 08/11/2022 | ITCI | Buy Now | Intra-Cellular Therapies | $72.73 | -1% | $75 → $72 | Maintains | Buy | Get Alert |
| 08/09/2022 | KOD | Buy Now | Kodiak Sciences | $2.44 | 268.85% | $5 → $9 | Maintains | Neutral | Get Alert |
| 08/04/2022 | HRMY | Buy Now | Harmony Biosciences | $34.35 | 74.67% | $64 → $60 | Maintains | Buy | Get Alert |
| 08/03/2022 | CERE | Buy Now | Cerevel Therapeutics Hldg | $40.59 | -33.48% | $30 → $27 | Maintains | Neutral | Get Alert |
| 07/13/2022 | RYTM | Buy Now | Rhythm Pharmaceuticals | $43.67 | -86.26% | — | Maintains | Neutral | Get Alert |
| 07/07/2022 | BTAI | Buy Now | BioXcel Therapeutics | $1.13 | 1581.42% | → $19 | Initiates | → Buy | Get Alert |
| 07/07/2022 | ITCI | Buy Now | Intra-Cellular Therapies | $72.73 | 1.75% | → $74 | Initiates | → Buy | Get Alert |
| 07/07/2022 | ATHA | Buy Now | Athira Pharma | $2.65 | 126.42% | → $6 | Initiates | → Buy | Get Alert |
| 07/07/2022 | ALEC | Buy Now | Alector | $4.89 | 206.75% | → $15 | Initiates | → Buy | Get Alert |
| 07/07/2022 | CERE | Buy Now | Cerevel Therapeutics Hldg | $40.59 | -26.09% | → $30 | Initiates | → Neutral | Get Alert |
| 07/07/2022 | HRMY | Buy Now | Harmony Biosciences | $34.35 | 86.32% | → $64 | Initiates | → Buy | Get Alert |
| 05/26/2022 | HALO | Buy Now | Halozyme Therapeutics | $52.75 | 13.74% | $48 → $60 | Maintains | Buy | Get Alert |
| 05/24/2022 | RYTM | Buy Now | Rhythm Pharmaceuticals | $43.67 | -83.97% | $8 → $7 | Maintains | Neutral | Get Alert |
| 05/24/2022 | KOD | Buy Now | Kodiak Sciences | $2.44 | 104.92% | $7 → $5 | Maintains | Neutral | Get Alert |
| 05/24/2022 | CYTK | Buy Now | Cytokinetics | $56.32 | 1.21% | $71 → $57 | Maintains | Buy | Get Alert |
| 05/11/2022 | KOD | Buy Now | Kodiak Sciences | $2.44 | 186.89% | $8 → $7 | Maintains | Neutral | Get Alert |
| 04/19/2022 | TGTX | Buy Now | TG Therapeutics | $19.56 | -74.44% | $8 → $5 | Maintains | Sell | Get Alert |
| 04/07/2022 | RYTM | Buy Now | Rhythm Pharmaceuticals | $43.67 | -79.39% | $10 → $9 | Maintains | Neutral | Get Alert |
| 11/15/2021 | TGTX | Buy Now | TG Therapeutics | $19.56 | 32.92% | — | Downgrade | Neutral → Sell | Get Alert |
| 04/28/2020 | ADVM | Buy Now | Adverum Biotechnologies | $7.18 | 136.77% | → $170 | Initiates | → Buy | Get Alert |
